tgct
Showing 1 - 4 of 4
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT Trial in Germany, Poland, Ukraine (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- +3 more
- AMB-05X
-
Berlin, Germany
- +4 more
Oct 5, 2022
TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)
Active, not recruiting
- TGCT
- Emactuzumab
- Placebo
-
Washington, District of Columbia
- +1 more
Sep 23, 2022
Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor Trial (AMB-05X)
Not yet recruiting
- Pigmented Villonodular Synovitis
- +2 more
- AMB-05X
- (no location specified)
Apr 22, 2022
